Ifp Advisors, Inc Maravai Lifesciences Holdings, Inc. Transaction History

Ifp Advisors, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$4.7 - $9.87 $1,856 - $3,898	-395 Reduced 81.44%	90 $0
Q3 2023 Oct 12, 2023	BUY	$9.14 - $12.85 $1,307 - $1,837	143 Added 41.81%	485 $4,000
Q2 2023 Aug 04, 2023	BUY	$12.09 - $15.0 $2,103 - $2,610	174 Added 103.57%	342 $4,000
Q1 2023 Apr 18, 2023	SELL	$12.99 - $16.48 $7,949 - $10,085	-612 Reduced 78.46%	168 $2,000
Q4 2022 Feb 07, 2023	BUY	$12.5 - $24.78 $6,750 - $13,381	540 Added 225.0%	780 $23,000
Q3 2022 Nov 08, 2022	BUY	$20.6 - $30.37 $2,698 - $3,978	131 Added 120.18%	240 $9,000
Q2 2022 Sep 06, 2022	BUY	$26.05 - $37.48 $2,839 - $4,085	109 New	109 $7,000
Q2 2022 Aug 12, 2022	SELL	$26.05 - $37.48 $2,839 - $4,085	-109 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$24.46 - $40.92 $2,666 - $4,460	109 New	109 $3,000
Q4 2021 Jan 12, 2022	SELL	$35.0 - $45.94 $7,000 - $9,188	-200 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$36.8 - $60.62 $7,359 - $12,124	200 New	200 $10,000
Q2 2021 Jul 13, 2021	SELL	$32.46 - $45.0 $1,623 - $2,250	-50 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$25.8 - $38.49 $1,290 - $1,924	50 New	50 $2,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.